Hydroxyapatite (HAp, Ca₅(PO₄)₃(OH), CAS 1306-06-5) is a calcium phosphate mineral that constitutes 97% of human tooth enamel, 70% of bone, and 60% of dentin by weight — making it the only remineralizing agent chemically identical to the body’s own hard tissue. Nano-hydroxyapatite (≤100 nm, D50 30-80 nm) remineralizes teeth through a dual biomimetic mechanism: (1) Physical filling and tubule occlusion — nano-HAp particles penetrate microscopic enamel defects (demineralized subsurface lesions 10-50 μm deep) and exposed dentinal tubules (1-5 μm diameter openings). The nanoparticles self-assemble into a continuous, homogeneous apatite layer via oriented attachment to the existing enamel crystallites, followed by Ostwald ripening (dissolution of smaller particles → re-precipitation onto larger crystals). (2) Sustained ion reservoir — nano-HAp serves as a Ca²⁺ and PO₄³⁻ ion source, maintaining supersaturation at the enamel-saliva interface and shifting the de/remineralization equilibrium toward remineralization even under acidic challenge (critical pH 5.5 for HAp). Clinical evidence: 10% nano-HAp toothpaste provided equivalent remineralization to 1450 ppm fluoride toothpaste in a 2021 Schlagenhauf RCT (n=190, 6-month non-inferiority). For hypersensitivity: 56% reduction in dentin sensitivity scores at 2 weeks (2020 Geeta study). Unlike fluoride which converts existing enamel to fluorapatite, nano-HAp directly deposits new hydroxyapatite identical to natural enamel — purely additive biomimetic repair. UPOR Biotech’s synthetic HAp is produced via controlled wet-chemical precipitation with no animal-derived material (BSE/TSE-free).

Nano-hydroxyapatite provides four unique, clinically validated benefits unmatched by any single alternative agent: (1) Enamel-identical biomimetic remineralization — Ca/P ratio 1.67, hexagonal crystal system P6₃/m, identical to biological enamel. Nano-HAp restores surface microhardness (SMH recovery 85-95% in vitro pH cycling models), repairs white spot lesions, and fills subsurface demineralization — without chemically modifying the enamel. (2) Non-fluoride safety profile — safe if swallowed (no fluorosis risk to developing dentition), making nano-HAp the preferred remineralizing agent for children’s toothpaste (≤8 years), pregnant women, fluoride-sensitive consumers, and the rapidly growing global natural/oral microbiome-friendly toothpaste category. (3) Natural tooth brightening via surface planarization — nano-HAp particles (~30-80 nm) fill nanoscale enamel surface irregularities, reducing diffuse light scattering and improving specular reflection. This produces a progressive, natural whitening effect without peroxide bleaching (no free radicals, no dentin penetration, no sensitivity side effect) or abrasive silica (no mechanical enamel wear). (4) Fast dentin hypersensitivity relief — 10% nano-HAp occludes exposed dentinal tubules within 2 weeks of twice-daily use (56% sensitivity reduction, 2020 Geeta study). Mechanism is physical occlusion (not neural desensitization like potassium nitrate), providing longer-lasting relief and cumulative benefit with continued use. In cosmetics, nano-HAp at 0.5-5% provides calcium-mediated keratinocyte differentiation enhancement, epidermal barrier reinforcement (increased ceramide synthesis), and UV-scattering particulate synergism with mineral sunscreen filters.

Nano-Hydroxyapatite (≤100 nm, D50 30-80 nm) — highest specific surface area (BET 60-120 m²/g), particle size smaller than dentinal tubule openings (1-5 μm) enabling physical penetration and tubule occlusion, optimal for oral care and cosmetics where nanoscale surface integration is critical. Self-assembles into continuous apatite layer on enamel via oriented attachment and Ostwald ripening. Micro-Hydroxyapatite (1-100 μm, D50 1-50 μm) — lower surface area (BET 5-20 m²/g), used where structural scaffolding is required: porous sintered bone graft blocks (200-500 μm macropores for osteoconduction), plasma-sprayed implant coatings (50-200 μm thickness, 30-50% porosity for bone ingrowth), and food fortification (FCC grade). β-Tricalcium Phosphate (β-TCP, Ca₃(PO₄)₂, Ca/P 1.5) — more soluble than HAp (Ksp ~10⁻²⁸ vs ~10⁻¹¹⁷), resorbs and is replaced by host bone in 6-12 months (vs HAp 2-5+ years for sintered blocks). Used for bone graft applications where rapid resorption is desired — not for oral care (too soluble, does not form stable enamel layer). CPP-ACP (Casein Phosphopeptide-Amorphous Calcium Phosphate) — milk-derived, stabilizes amorphous calcium phosphate nanoclusters via casein phosphopeptide binding, provides bioavailable Ca²⁺/PO₄³⁻ ions for natural remineralization but does NOT directly deposit crystalline hydroxyapatite. Dicalcium Phosphate Dihydrate (DCPD, CaHPO₄·2H₂O, Ca/P 1.0) — low-cost abrasive/polishing agent in toothpaste, minimal remineralization activity. UPOR Biotech provides nano-HAp (oral care/cosmetic) and micro-HAp (medical/food) with full particle size distribution documentation and Ca/P ratio verification by ICP-OES.

Hydroxyapatite and fluoride operate via fundamentally different, complementary mechanisms — they are not competitors but synergistic partners in comprehensive oral care. Fluoride (NaF, SnF₂, Na₂FPO₃ — 1000-1500 ppm) — fluoride ions substitute for OH⁻ in the hydroxyapatite lattice, converting surface enamel to fluorapatite (Ca₅(PO₄)₃F). Fluorapatite has a lower critical pH (4.5 vs 5.5 for HAp), making enamel more resistant to dietary acid challenges. However, fluoride does not supply calcium or phosphate ions — it relies entirely on salivary mineral content for remineralization and cannot fill existing enamel defects. Fluoride is the undisputed caries prevention gold standard with 70+ years of Level I evidence. Limitations: fluorosis risk in children ≤8 years (disruption of amelogenesis during crown development — mottled enamel), no direct dentin tubule occlusion (no hypersensitivity mechanism), no whitening benefit. Nano-Hydroxyapatite (10%) — directly supplies Ca²⁺ and PO₄³⁻ ions, physically fills enamel defects and dentinal tubules, deposits new HAp identical to natural enamel. Provides natural whitening via surface smoothing and fast sensitivity relief via tubule occlusion — benefits fluoride cannot deliver. Clinical evidence: the 2021 Schlagenhauf RCT (n=190) found 10% nano-HAp toothpaste non-inferior to 1450 ppm fluoride toothpaste for caries prevention over 6 months. The 2020 Geeta study found nano-HAp comparable to fluoride for remineralization with superior surface smoothness and cosmetic brightening. Optimal comprehensive strategy: nano-HAp 10% (remineralization + whitening + tubule occlusion) + fluoride 1000-1500 ppm Na₂FPO₃ (acid resistance + caries prevention) = dual-mechanism oral care covering all four clinical endpoints. For non-fluoride formulations: nano-HAp 10% + xylitol 5-10% (anti-cariogenic via inhibition of Streptococcus mutans glycolysis + salivary stimulation) is the clinically validated gold standard.

Every shipment includes: COA (XRD phase purity ≥97% hydroxyapatite vs JCPDS 09-0432; Ca/P molar ratio 1.67 ±0.02 by ICP-OES; particle size D50/D90 by dynamic light scattering or laser diffraction; BET surface area by nitrogen adsorption; heavy metals Pb ≤5 ppm/As ≤2 ppm/Hg ≤1 ppm/Cd ≤1 ppm; trace elements Fe/Mg/Na/K each ≤500 ppm; loss on ignition ≤3%; microbial panel per USP <61>/<62> and EP <2.6.12>/<2.6.13>), MSDS, XRD Diffractogram (phase identity verification vs JCPDS 09-0432 standard — signed and dated), FTIR Spectrum (OH⁻ 3572 cm⁻¹, PO₄³⁻ 1090/1040/962/603/566 cm⁻¹ confirmation; carbonate-free verification), SEM/TEM Micrograph (particle morphology, size, and dispersion state — nano grade ≤100 nm verification), Ca/P Ratio Report (ICP-OES, triplicate analysis), ISO 10993 Biocompatibility Certificate (cytotoxicity Grade 0, skin sensitization, intracutaneous irritation — medical grade only), BSE/TSE-Free Statement (synthetic — no animal-derived raw materials), Non-GMO Statement, Allergen Statement (soy-free, gluten-free, dairy-free), HALAL Certificate, KOSHER Certificate, ISO 22000 + HACCP, ISO 9001:2015, ISO 13485 (medical grade only — Quality Management System for Medical Devices), FDA Facility Registration, Stability Data (25°C/60%RH real-time 36-month; particle size stability verified at 3/6/12/24/36 months; XRD phase purity re-verified at 12/24/36 months), and Complete Lot Traceability from raw material precursors to finished product. Free sample available for qualified B2B buyers — specify nano or micro grade. MOQ: 1 kg. All documents in English.